anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

27 Cost Of Inaction

Loop collection for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Matching slides 31,900
Current window 22,501-22,530
Pages 1,064
Rows per page 30
Loop: 27 Cost Of Inactionclear collectionreset all
18 30 60

Loop

22,501-22,530 of 31,900

filter-aware
06
The slide uses a rhetorical question as a title to frame the data as evidence of a conflict of interest.Blackwells Capital | Activist Presentation Deck | 15 slides · Blackwells Capital
Activist deck Activist investor Beat · Expose ContradictionLoop · Analogy1 hit
07
The slide uses highlighted text in source documents to draw attention to specific governance responsibilities.Blackwells Capital | Activist Presentation Deck | 15 slides · Blackwells Capital
Activist deck Activist investor Beat · Expose ContradictionLoop · Cost Of Inaction1 hit
08
Uses a 'before-after' or 'contradiction' framing by juxtaposing corporate policy text against specific company actions.Blackwells Capital | Activist Presentation Deck | 15 slides · Blackwells Capital
Activist deck Activist investor Beat · Expose ContradictionLoop · Cost Of Inaction1 hit
09
Uses callouts to link specific policy text to the central argument of governance failure.Blackwells Capital | Activist Presentation Deck | 15 slides · Blackwells Capital
Activist deck Activist investor Beat · Expose ContradictionLoop · Cost Of Inaction1 hit
10
Uses a rhetorical question structure to challenge the legitimacy of an SEC filing.Blackwells Capital | Activist Presentation Deck | 15 slides · Blackwells Capital
Activist deck Activist investor Beat · Expose ContradictionLoop · Cost Of Inaction1 hit
11
Uses a 'hypocrisy' framing by juxtaposing corporate values against specific actions.Blackwells Capital | Activist Presentation Deck | 15 slides · Blackwells Capital
Activist deck Activist investor Beat · Expose ContradictionLoop · Cost Of Inaction1 hit
12
The slide uses visual evidence (screenshots of the opponent's deck) to expose a lack of transparency.Blackwells Capital | Activist Presentation Deck | 15 slides · Blackwells Capital
Activist deck Activist investor Beat · Expose ContradictionLoop · Cost Of Inaction1 hit
13
The slide includes a screenshot of a page from a Disney investor presentation (page 45) to support the argument.Blackwells Capital | Activist Presentation Deck | 15 slides · Blackwells Capital
Activist deck Activist investor Beat · Expose ContradictionLoop · Cost Of Inaction1 hit
14
Blackwells Capital | Activist Presentation Deck | 15 slidesBlackwells Capital | Activist Presentation Deck | 15 slides · Blackwells Capital
Activist deck Activist investor Beat · TimelineLoop · Cost Of Inaction1 hit
15
Blackwells Capital | Activist Presentation Deck | 15 slidesBlackwells Capital | Activist Presentation Deck | 15 slides · Blackwells Capital
Activist deck Activist investor Beat · Demand ListLoop · Cost Of Inaction1 hit
10
The slide uses Kaplan-Meier survival curves to illustrate the clinical problem.Boundless Bio | IPO Presentation Deck | 51 slides · Boundless Bio
Pitch deck Investment bank Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
11
The slide uses a visual 'X' to indicate the lack of efficacy for amplifications across multiple drug classes.Boundless Bio | IPO Presentation Deck | 51 slides · Boundless Bio
Pitch deck Investment bank Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
12
The slide uses a color-coded matrix to illustrate clinical failure or limited efficacy in amplified tumors.Boundless Bio | IPO Presentation Deck | 51 slides · Boundless Bio
Pitch deck Investment bank Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
13
The slide uses a horizontal timeline to map scientific discovery (Nature/Science papers) against corporate milestones (funding, clinical trials).Boundless Bio | IPO Presentation Deck | 51 slides · Boundless Bio
Pitch deck Investment bank Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
10
The slide uses a Kaplan-Meier curve to visually demonstrate the 'problem' (rapid progression) and a callout box to quantify the market opportunity.CARGO Therapeutics | IPO Presentation Deck | 29 slides · CARGO Therapeutics
Pitch deck Investment bank Beat · ProblemLoop · Cost Of Inaction1 hit
11
The slide features a stylized 3D rendering of a cell, likely representing the therapeutic target or mechanism of action.CARGO Therapeutics | IPO Presentation Deck | 29 slides · CARGO Therapeutics
Pitch deck Investment bank Loop · Cost Of Inaction1 hit
12
Includes Kaplan-Meier survival curves and a summary table of clinical outcomes.CARGO Therapeutics | IPO Presentation Deck | 29 slides · CARGO Therapeutics
Pitch deck Investment bank Beat · TractionLoop · Cost Of Inaction1 hit
13
The slide uses a process flow diagram to illustrate the clinical trial stages.CARGO Therapeutics | IPO Presentation Deck | 29 slides · CARGO Therapeutics
Pitch deck Investment bank Beat · TractionLoop · Cost Of Inaction1 hit
14
The slide uses a comparison table to contrast clinical trial data for CRG-022 against historical benchmarks for ZUMA-1, JULIET, and TRANSCEND.CARGO Therapeutics | IPO Presentation Deck | 29 slides · CARGO Therapeutics
Pitch deck Investment bank Beat · TractionLoop · Cost Of Inaction1 hit
15
Kaplan-Meier survival curve shown.CARGO Therapeutics | IPO Presentation Deck | 29 slides · CARGO Therapeutics
Pitch deck Investment bank Beat · TractionLoop · Cost Of Inaction1 hit
11
The slide uses a three-column layout to categorize the problem into prevalence, clinical challenges, and patient profile.CG Oncology | IPO Presentation Deck | 45 slides · CG Oncology
Pitch deck Investment bank Beat · ProblemLoop · Cost Of Inaction1 hit
12
The diagram shows the progression of tumor invasion through the bladder wall layers (Lamina Propria, Inner Muscle, Deep Muscle).CG Oncology | IPO Presentation Deck | 45 slides · CG Oncology
Pitch deck Investment bank Beat · Market SizeLoop · Cost Of Inaction1 hit
13
The slide uses a process flow that transitions into a decision tree/matrix based on risk levels.CG Oncology | IPO Presentation Deck | 45 slides · CG Oncology
Pitch deck Investment bank Loop · Cost Of Inaction1 hit
14
The slide highlights the regulatory environment as a key driver for development, citing specific FDA definitions and successful approvals.CG Oncology | IPO Presentation Deck | 45 slides · CG Oncology
Pitch deck Investment bank Loop · Cost Of Inaction1 hit
15
The slide uses a hierarchical tree structure to map clinical trials to specific patient segments (Intermediate vs High Risk, BCG-naïve/exposed/unresponsive).CG Oncology | IPO Presentation Deck | 45 slides · CG Oncology
Pitch deck Investment bank Loop · Cost Of Inaction1 hit
16
Includes FDA Fast Track and Breakthrough Therapy designations.CG Oncology | IPO Presentation Deck | 45 slides · CG Oncology
Pitch deck Investment bank Loop · Cost Of Inaction1 hit
17
BOND-003 study data.CG Oncology | IPO Presentation Deck | 45 slides · CG Oncology
Pitch deck Investment bank Loop · Cost Of Inaction1 hit
18
Efficacy data cutoff as of October 5, 2023. Footnote indicates some patients excluded from 6-month assessment.CG Oncology | IPO Presentation Deck | 45 slides · CG Oncology
Pitch deck Investment bank Beat · TractionLoop · Cost Of Inaction1 hit
19
The slide uses a swimmer plot to visualize individual patient response durations, including complete response, recurrence, and reinduction events.CG Oncology | IPO Presentation Deck | 45 slides · CG Oncology
Pitch deck Investment bank Beat · TractionLoop · Cost Of Inaction1 hit
20
BOND-003 clinical trial safety data.CG Oncology | IPO Presentation Deck | 45 slides · CG Oncology
Pitch deck Investment bank Loop · Cost Of Inaction1 hit